USPTO serial 88091978
REFLECTIONBIO - BY PATIENTS, FOR PATIENTS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 22, 2019
- Examiner
- DANTZLER, LAUREN ALEXANDRIA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with REFLECTIONBIO - BY PATIENTS, FOR PATIENTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
REFLECTION BIOTECHNOLOGIES LIMITED
Shatin, HK
Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
REFLECTION BIOTECHNOLOGIES LIMITED
Shatin, HK
Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
REFLECTION BIOTECHNOLOGIES LIMITED
New Territories, HK
Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kerrijane John
Kerrijane John Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, medical and veterinary preparations for genetically based diseases and rare disorders; sanitary preparations for medical purposes; dietetic food and substances, in the nature of sugar adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; medicines for human purposes for the treatment of genetically based diseases and rare disorders; pharmaceuticals for genetically based diseases and rare disorders; pharmaceutical preparations for use in the treatment of genetically based diseases and rare disorders; pharmaceutical preparations for gene therapy and cell therapy | SECTION 8 - CANCELLED | — |
| 042 | design and development of computer hardware and software; research and development of orphan drugs | SECTION 8 - CANCELLED | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; agricultural services, namely, compost spreading; forestry services, namely, insecticide spraying for forestry; health and medical counselling; providing health care and medical information; providing a website featuring educational information regarding rare diseases, orphan drugs, gene therapy, cell therapy and other treatment options; Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advisory and information services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; Health care advisory and information services for patients and their families regarding the coordination of medical services; Advice and consultation services, namely, providing advice, information and assistance to patients and their families in dealing with medical service providers, hospitals, insurance companies, and others involved in patient care | SECTION 8 - CANCELLED | — |
| 045 | Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advocacy services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; providing patient advocacy services in the field of gene therapy and cell therapy; providing case management services, namely, coordinating patient and family health care medical services; health care advocacy services for patients and their families regarding the coordination of medical services; health care case management services, namely, medical care coordination for patients and families | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
- Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
- Other trademarks owned by REFLECTION BIOTECHNOLOGIES LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named REFLECTIONBIO - BY PATIENTS, FOR PATIENTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 22, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 22, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 21, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 21, 2019 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 18, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 6, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 6, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 17, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 26, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 26, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 26, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 26, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 26, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 15, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 15, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 12, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 10, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2018 | NWAP | NEW APPLICATION ENTERED | — |